Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Summary 
Currently, Jean-Paul Kress holds the position of Chairman at ERYTech Pharma SA and CEO & Chairman-Management Board at MorphoSys AG.

Dr. Kress previously held the position of President-International & Executive Vice President at Biogen, Inc., President, Chief Executive Officer & Director at Syntimmune, Inc., President & Chief Executive Officer for Sanofi Pasteur MSD SNC and Senior Vice President & Head-North America at Genzyme Corp.

Jean-Paul Kress received an undergraduate degree and a graduate degree from École Normale Supérieure and a doctorate from Faculté De Médecine Necker Enfants Malades Université.


Current positions of Jean-Paul Kress 
NameTitle Since
MorphoSys AG
(Biotechnology & Medical Research)
CEO & Chairman-Management Board 2019
ERYTECH Pharma S.A.
(Biotechnology & Medical Research)
Chairman 2019


Jean-Paul Kress: Personal Network 
Most Read News 
08/02JACK DORSEY : Twitter's Dorsey leads $29 billion buyout of lending pioneer Afterpay
RE
08/03CARLOS TAVARES : Stellantis lifts margin goal as Tavares' turnaround kicks in
RE
07/28MARK ZUCKERBERG : Facebook's slowdown warning hangs over strong ad sales, while Zuckerberg talks 'metaverse'
RE
07/20JEFF BEZOS : billionaire Bezos has successful suborbital jaunt
RE
08/02MICHAEL EVANS : London Shares Rise as China Regulatory Concerns Ease
DJ
07/26JEFF BEZOS : Bezos-backed plant food firm NotCo joins unicorn club after latest funding
RE
07/26MICHAEL KLEIN : EV maker Lucid rises in Nasdaq debut after merger with Klein-backed SPAC
RE
07/27RAJESH KUMAR : GE warns of inflationary pressure after lifting cash flow estimate
RE
07/26JEFF BEZOS : Bezos offers NASA $2 billion in exchange for moon mission contract
RE
07/27IAN READ : Exclusive-Rivian ready to invest $5 billion in second U.S. assembly plant -document
RE
More news


© 2021 People and Ownership :   
Jean-Paul Kress : Connections